Antiatherosclerotic Phenotype of Perivascular Adipose Tissue Surrounding the Saphenous Vein in Coronary Artery Bypass Grafting.
coronary artery bypass surgery
epicardial fat
perivascular fat
saphenous vein
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
06 04 2021
06 04 2021
Historique:
pubmed:
30
3
2021
medline:
21
10
2021
entrez:
29
3
2021
Statut:
ppublish
Résumé
Background Perivascular adipose tissue (PVAT) is associated with metabolically driven chronic inflammation called metaflammation, which contributes to vascular function and the pathogenesis of vascular disease. The saphenous vein (SV) is commonly used as an essential conduit in coronary artery bypass grafting, but the long-term patency of SV grafts is a crucial issue. The use of the novel "no-touch" technique of SV harvesting together with its surrounding tissue has been reported to result in good long‑term graft patency of SV grafts. Herein, we investigated whether PVAT surrounding the SV (SV-PVAT) has distinct phenotypes compared with other PVATs of vessels. Methods and Results Fat pads were sampled from 48 patients (male/female, 32/16; age, 72±8 years) with coronary artery disease who underwent elective coronary artery bypass grafting. Adipocyte size in SV-PVAT was significantly larger than the sizes in PVATs surrounding the internal thoracic artery, coronary artery, and aorta. SV-PVAT and PVAT surrounding the internal thoracic artery had smaller extents of fibrosis, decreased gene expression levels of fibrosis-related markers, and less metaflammation, as indicated by a significantly smaller extent of cluster of differentiation 11c-positive M1 macrophage infiltration, higher gene expression level of adiponectin, and lower gene expression levels of inflammatory cytokines, than did PVATs surrounding the coronary artery and aorta. Expression patterns of adipocyte developmental and pattern-forming genes were totally different among the PVATs of the vessels. Conclusions The phenotype of SV-PVAT, which may result from inherent differences in adipocytes, is closer to that of PVAT surrounding the internal thoracic artery than that of PVAT surrounding the coronary artery or that of PVAT surrounding the aorta. SV-PVAT has less metaflammation and consecutive adipose tissue remodeling, which may contribute to high long-term patency of grafting when the no-touch technique of SV harvesting is used.
Identifiants
pubmed: 33779243
doi: 10.1161/JAHA.120.018905
pmc: PMC8174366
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e018905Références
Arterioscler Thromb Vasc Biol. 2009 May;29(5):781-6
pubmed: 19229071
Ann Thorac Surg. 2005 Sep;80(3):939-44
pubmed: 16122459
Am J Physiol Heart Circ Physiol. 2014 May;306(9):H1314-23
pubmed: 24610918
Am Heart J. 2007 Jun;153(6):907-17
pubmed: 17540190
J Thorac Cardiovasc Surg. 2006 Aug;132(2):373-8
pubmed: 16872965
Interact Cardiovasc Thorac Surg. 2011 Dec;13(6):626-30
pubmed: 21908888
Nature. 2017 Feb 8;542(7640):177-185
pubmed: 28179656
Circulation. 2003 Nov 18;108(20):2460-6
pubmed: 14581396
Front Physiol. 2018 Feb 13;9:3
pubmed: 29487532
Interact Cardiovasc Thorac Surg. 2011 Feb;12(2):170-3
pubmed: 21051379
Circ Res. 2009 Feb 27;104(4):541-9
pubmed: 19122178
J Am Heart Assoc. 2021 Apr 6;10(7):e018905
pubmed: 33779243
Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6676-81
pubmed: 16617105
J Lipid Res. 2005 Nov;46(11):2347-55
pubmed: 16150820
Arterioscler Thromb Vasc Biol. 2016 May;36(5):825-34
pubmed: 27013610
Adipocyte. 2018;7(3):156-165
pubmed: 29956579
PLoS One. 2013 Nov 11;8(11):e79245
pubmed: 24244459
Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1576-82
pubmed: 20489168
Arch Pathol Lab Med. 2007 Mar;131(3):481-7
pubmed: 17516753
Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E298-307
pubmed: 16985259
J Thorac Cardiovasc Surg. 2016 Jun;151(6):1704-8
pubmed: 26971376
Scand Cardiovasc J. 1999;33(6):323-9
pubmed: 10622542
Clin Sci (Lond). 2012 Jan;122(1):1-12
pubmed: 21910690
Br J Surg. 2001 Sep;88(9):1209-15
pubmed: 11531869
Life Sci. 2013 Dec 18;93(25-26):1023-32
pubmed: 24200844
Ann Cardiothorac Surg. 2013 Jul;2(4):519-26
pubmed: 23977631
J Thorac Cardiovasc Surg. 2011 Jan;141(1):145-50
pubmed: 20381817
Angiology. 2013 May;64(4):293-9
pubmed: 22569406
Arterioscler Thromb Vasc Biol. 2013 May;33(5):1077-84
pubmed: 23471228
Scand J Thorac Cardiovasc Surg. 1996;30(1):41-4
pubmed: 8727856
Circ J. 2011;75(4):766-72
pubmed: 21415547
Trends Pharmacol Sci. 2004 Dec;25(12):647-53
pubmed: 15530643
Sci Rep. 2014 Nov 06;4:6943
pubmed: 25373918
Diabetologia. 2012 May;55(5):1514-25
pubmed: 22327346
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):880-891
pubmed: 29496660
Arq Bras Cardiol. 2008 Jun;90(6):356-62
pubmed: 18592087
J Am Coll Cardiol. 2018 Jan 30;71(4):414-425
pubmed: 29389358
Circulation. 2013 Jul 2;128(1):9-18
pubmed: 23685742
J Am Heart Assoc. 2019 Jan 22;8(2):e011147
pubmed: 30638109
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1738-1747
pubmed: 29954752
Ann Card Anaesth. 2016 Jul-Sep;19(3):481-8
pubmed: 27397453